[{"Assets_0_Q3_USD":94378000.0,"CommonStockSharesOutstanding_0_Q3_shares":23160875.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-39312000.0,"NetIncomeLoss_3_Q3_USD":-41825000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":9405000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":2151000.0,"StockholdersEquity_0_Q3_USD":29854000.0,"Ticker":"MRSN","CIK":"1442836","name":"MERSANA THERAPEUTICS, INC.","OfficialName":"Mersana Therapeutics Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"345233797.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181113"}]